| # | Drug | Count |
|---|---|---|
| 0 | OCTREOTIDE ACETATE | 316 |
| 1 | CAPECITABINE | 222 |
| 2 | PREDNISONE | 221 |
| 3 | LETROZOLE | 220 |
| 4 | EVEROLIMUS | 212 |
| 5 | METHOTREXATE SODIUM | 194 |
| 6 | METHOTREXATE | 179 |
| 7 | RIBOCICLIB | 179 |
| 8 | FULVESTRANT | 177 |
| 9 | ADALIMUMAB | 176 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TEBENTAFUSP | 8 | 0.0133 |
| 1 | TEDIZOLID PHOSPHATE | 10 | 0.0125 |
| 2 | OCTREOTIDE ACETATE | 316 | 0.0103 |
| 3 | CHLOROTHIAZIDE SODIUM | 6 | 0.0065 |
| 4 | RIBOCICLIB | 179 | 0.0055 |
| 5 | FULVESTRANT | 177 | 0.0053 |
| 6 | CAPSICUM ANNUUM, CETRARIA ISLANDICA, FUCUS VESICULOSUS, GLANDULA SUPRARENALIS SUIS, THYROIDINUM (SUIS), CADMIUM IODATUM, HYDRANGEA ARBORESCENS, PHOSPHORICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), STRONTIUM CARBONICUM, URANIUM NITRICUM, X-RAY | 5 | 0.0049 |
| 7 | VANCOMYCIN HYDROCHLORIDE | 40 | 0.0048 |
| 8 | CHLOROTHIAZIDE | 6 | 0.0048 |
| 9 | EXEMESTANE | 101 | 0.0047 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 549 |
| 1 | Corticosteroid [EPC] | 446 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 399 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 391 |
| 4 | Aromatase Inhibitor [EPC] | 328 |
| 5 | Benzodiazepine [EPC] | 268 |
| 6 | Platinum-based Drug [EPC] | 248 |
| 7 | mTOR Inhibitor Immunosuppressant [EPC] | 217 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 197 |
| 9 | Estrogen Receptor Antagonist [EPC] | 192 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 25 | 0.0363 |
| 1 | Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] | 8 | 0.0133 |
| 2 | Farnesyltransferase Inhibitor [EPC] | 1 | 0.0128 |
| 3 | Estrogen Receptor Antagonist [EPC] | 192 | 0.0047 |
| 4 | Interleukin-17 Receptor A Antagonist [EPC] | 9 | 0.0044 |
| 5 | Provitamin D2 Compound [EPC] | 118 | 0.0040 |
| 6 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 3 | 0.0036 |
| 7 | Somatostatin Analog [EPC] | 24 | 0.0035 |
| 8 | Peroxisome Proliferator-activated Receptor Agonist [EPC] | 3 | 0.0033 |
| 9 | Vasopressin Receptor Agonist [EPC] | 1 | 0.0030 |